The sooner, the better: early clearance of plasma circulating tumor DNA in patients with advanced KRAS G12C mutant non-small cell lung cancer

Transl Lung Cancer Res. 2024 Feb 29;13(2):215-219. doi: 10.21037/tlcr-23-838. Epub 2024 Feb 20.
No abstract available

Keywords: Kirsten rat sarcoma viral oncogene homologue glycine-to-cysteine (KRAS G12C); circulating tumor DNA (ctDNA); non-small cell lung cancer (NSCLC).

Publication types

  • Editorial
  • Comment